4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-011948
Chief Scientific Officer sold 7,400 shares at an average $33.46 ($247,578)
- Chief Scientific Officer acquired 7,400 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBINS HARLAN S Chief Scientific Officer | 2020-02-20 | Option exercise | +7,400 | $6.32 | $46,768 | 78,079 | D |
| ROBINS HARLAN S Chief Scientific Officer | 2020-02-20 | Sale | −800 | $32.85 | $26,280 | 77,279 | D |
| ROBINS HARLAN S Chief Scientific Officer | 2020-02-20 | Sale | −6,600 | $33.53 | $221,298 | 70,679 | D |
| Derivatives | |||||||
| ROBINS HARLAN S Chief Scientific Officer | 2020-02-20 | Option exercise · Stock Option (Right to Buy) | −7,400 | 555,600 | D | ||
| Open-market sales · 7,400 sh · avg $33.46 · $247,578 | |||||||
Loading xslF345X03/doc4.xml…